Latest News

FDA News Release FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
by

The U.S. Food and Drug Administration announced a Roadmap to Reducing Animal Testing in Preclinical Safety Studies by leveraging more effective, human relevant methods including technologies like our Human-on-a-Chip! This exciting announcement outlines a 3-year strategic … Read More

by

Our team had the privilege of the Society of Toxicology (SOT) Annual Meeting and ToxExpo 2025 March 16-20th.  SOT brought experts in the field of toxicology together for five days of scientific sessions, poster presentations, and … Read More

by

Ask Me Anything: Body-On-A-Chip Michael Shuler, PhD was featured on Technology Network’s Ask Me Anything: Body-On-A-Chip webinar and answered questions from a live audience.  January 31, 2025: Hosted by Technology Networks, Hesperos President Michael Shuler, PhD, … Read More

Title of a scientific journal article that reads "Microphysiological system to address the opioid crisis: A novel multi-organ model of acute opioid overdose and recovery"
by

ORLANDO, FLORIDA – Researchers from Hesperos and the University of Central Florida have developed a groundbreaking model using human induced pluripotent stem cell (iPSC)-derived cortical neurons to better understand and combat Alzheimer’s disease (AD). Their research, published in Alzheimer’s and Dementia, aims to improve our understanding and treatment of the disease.

by

FOR IMMEDIATE RELEASE ORLANDO, FL – October 24, 2024 – Hesperos, a leader in human-on-a-chip technology, has announced a breakthrough with the development of a human induced pluripotent stem cell (iPSC)-derived model of peripheral myelination. Published … Read More

Headline of an article that reads "A functional aged human iPSC-cortical neuron model recapitulates Alzheimer's disease, senescence, and the response to therapeutics," in purple text.
by

ORLANDO, FLORIDA – Researchers from Hesperos and the University of Central Florida have developed a groundbreaking model using human induced pluripotent stem cell (iPSC)-derived cortical neurons to better understand and combat Alzheimer’s disease (AD). Their research, published in Alzheimer’s and Dementia, aims to improve our understanding and treatment of the disease.

by

Watch the Presentation

Microphysiological Systems as Applied for Rare Diseases Therapeutic Development

Play Video

Hesperos Chief Scientist Dr. J Hickman was a featured speaker at NIH Rare Disease Day, covering how Human-on-a-chip systems are supporting rare diease therapuetics.  His talk, titled "Rare Story #3: Microphysiological Systems as Applied for Rare Diseases Therapeutic Development," presented Hesperos's commerically available models and how they have been used to test the efficacy of new pharmaceuticals.

NIH Rare Disease Day brought speakers from Congress, the FDA, Industry, Academia, and patient advocates together to discuss ways to accelerate development of new therapeutics for this underserved population.  View Dr. Hickman's talk below or

Click here to watch the full conference on NIH.gov

by

Development of a Malaria-on-a-Chip Model doi.org/10.1038/s41598-023-35694-4 Model developed to study Malaria and potential therapeutics Press Release Link to Publication Hesperos scientists have published a groundbreaking study in Scientific Reports, a Nature journal. The publication, titled “Development … Read More